Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for anemia control and erythropoietin dose reduction in chronic hemodialysis patients
IRCT20180122038471N1Phase 3Completed
- Sponsor
- Urology Research Centre
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of pentoxifylline in anaemia (2 arms), sponsored by Urology Research Centre. Primary endpoints: Anemia control and Reduction in intravenous erythropoietin requirement. Started Jan 2018; status: completed.
02
Drugs
pentoxifylline
03
Conditions
anaemia
Beyond the preview
Go deeper on IRCT20180122038471N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180122038471N1.